Li Deng-Ke
Keine laufenden Positionen mehr
Profil
Li Deng-Ke served as President, CEO, CFO, Director & CAO at Rich Pharmaceuticals, Inc. from 2012 to 2013.
Prior to that, he worked as a Technician at KTV Ltd.
Mr. Deng-Ke received his undergraduate degree from Sichuan Normal University in 2006.
Ehemalige bekannte Positionen von Li Deng-Ke
Unternehmen | Position | Ende |
---|---|---|
RICH PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 29.03.2013 |
KTV Ltd. | Corporate Officer/Principal | - |
Ausbildung von Li Deng-Ke
Sichuan Normal University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Rich Pharmaceuticals, Inc.
Rich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rich Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages on developing innovative therapies in oncology. It develops RP-323 for the treatment of Hodgkin’s lymphoma, Acute Myelogenous Leukemia, and to cause elevation of white blood cells in patients depleted of these elements due to various conditions. The company was founded on August 9, 2010 and is headquartered in Beverly Hills, CA. | Health Technology |
KTV Ltd. |